MELA Sciences (MELA)
MELA Sciences Revenues: 0.0113M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MELA Revenues Rankings
| Overall | 0th percentile | 4414 of 4432 |
| Sector | 1st percentile | 463 of 470 in Healthcare |
| Industry | 0th percentile | 67 of 67 in Medical Instruments & Supplies |
MELA Revenues Range, Past 5 Years
| Minimum | 0.0113M | Mar 2012 |
| Maximum | 0.0113M | Mar 2012 |
| Average | 0.0113M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these MELA related companies
MELA News
$MELA advisor shows STRONG BUY. (I hope they're right--- is something good just around the corner?)
about 3 days ago by Johnnie_Bravo
about 3 days ago by Johnnie_Bravo
Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews
May 25, 8:20AM Marketwire
May 25, 8:20AM Marketwire
$P http://stks.co/3xss $P $ROSG $GTIM $MELA $DMD $FONR $AMET Full blog post here http://stks.co/3xst
about 7 days ago by LincolnList
about 7 days ago by LincolnList
Unusual 11 Mid-Day Movers 05/23: (SCHS) (AMBT) (PCX) Higher; (DELL) (EGLE) (GENE) Lower
May 23, 2:28PM Street Insider
May 23, 2:28PM Street Insider
$MELA has gone from $4.50 to $2's in less than 3 weeks. Oversold.. Skin Cancer machine rollout. http://stks.co/3xIB
about 8 days ago by EPS_MomentuM
about 8 days ago by EPS_MomentuM
$MELA launched skin cancer Machine for commercial use last qtr, Maybe they found a big buyer.. http://stks.co/3xHr
about 8 days ago by EPS_MomentuM
about 8 days ago by EPS_MomentuM
$MELA had its commercial launch , and by 2013 its revenues estimated to rise over 500%
about 8 days ago by EPS_MomentuM
about 8 days ago by EPS_MomentuM
RT @Urbane_Gorilla RT @pennystocksusa: $MELA When will the bleed stop, from $4.50 to $2.50 in 15 days. **Nice consolidation area at 2.00ish
about 8 days ago by Ammeo
about 8 days ago by Ammeo
MELA Sciences, Inc. [MELA] to Ring The NASDAQ Stock Market Opening Bell
May 04, 10:00AM GlobeNewswire
May 04, 10:00AM GlobeNewswire
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); First Commercial Revenue From MelaFind
May 04, 8:40AM Street Insider
May 04, 8:40AM Street Insider
MELA Sciences to Present at the 37th Annual Deutsche Bank Health Care Conference
Apr 24, 4:30PM Marketwire
Apr 24, 4:30PM Marketwire
$MELA Downside Blowoff - 15 Minute Up Reversal - Green bar after 8 red bars
about 43 days ago by TradeIdeasQuant
about 43 days ago by TradeIdeasQuant
$MELA forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/30P4
about 70 days ago by RecogniaEvents
about 70 days ago by RecogniaEvents
$MELA filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/2zUd
about 71 days ago by MarketBrief
about 71 days ago by MarketBrief
$MELA forms bullish "Continuation Diamond" chart pattern. http://stks.co/2iqO
about 84 days ago by RecogniaEvents
about 84 days ago by RecogniaEvents
$MELA http://stks.co/2hxd from watch list over $5 on gap up - shitch to 5-min charts
about 85 days ago by StockTiger
about 85 days ago by StockTiger
MELA Sciences (MELA) Reports Study Indicates MelaFind Improves Detection of Melanoma
Feb 23, 7:39AM Street Insider
Feb 23, 7:39AM Street Insider
MELA Sciences (MELA) Enters Extended MelaFind Manufacturing Contract with Askion GmbH
Jan 11, 7:31AM Street Insider
Jan 11, 7:31AM Street Insider
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); Updating Earnings Model For Offering
Jan 05, 7:53AM Street Insider
Jan 05, 7:53AM Street Insider
MELA Sciences Announces Pricing of Underwritten Public Offering of Common Stock
Dec 16, 9:23AM Marketwire
Dec 16, 9:23AM Marketwire
MELA Sciences to Present at Piper Jaffray 23rd Annual Healthcare Conference
Nov 22, 7:00AM Marketwire
Nov 22, 7:00AM Marketwire
Needham & Company Reiterates a 'Buy' on MELA Sciences (MELA); Updating Our Earnings Model
Nov 21, 7:41AM Street Insider
Nov 21, 7:41AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MELA | 2.55 | -0.06 | -2.30% | 79.14M |
| MEI | 7.45 | -0.13 | -1.72% | 280.61M |
| MEG | 3.49 | -0.17 | -4.64% | 85.42M |
| MEDW | 14.33 | -0.21 | -1.44% | 119.08M |
| MED | 18.07 | -0.79 | -4.19% | 280.27M |
| MEAS | 32.91 | -0.63 | -1.88% | 503.77M |
| MEAD | 3.54 | +0.00 | +0.00% | 4.354M |
| MAXY | 5.81 | -0.06 | -1.02% | 163.01M |
| MAV | 15.16 | +0.00 | +0.00% | |
| MATW | 29.98 | -0.49 | -1.61% | 864.43M |
